The consensus molecular subtypes of colorectal cancer
2015 · Nature Medicine · 5,121 citations
https://doi.org/10.1038/nm.3967
D
David Barras
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
8.4K
Citations
27
h-index
38
i10-index
David Barras is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Colorectal Cancer Treatments and Studies. The author has an h-index of 27, co-authored 105 publications.
ORCID: 0000-0001-8985-4704Papers by this author
worksPGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
2024 · Nature · 174 citations
https://doi.org/10.1038/s41586-024-07352-w
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
2018 · Oncogene · 128 citations
https://doi.org/10.1038/s41388-018-0624-2
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
2024 · Nature · 99 citations
https://doi.org/10.1038/s41586-024-08257-4
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma
2016 · BMC Cancer · 48 citations
https://doi.org/10.1186/s12885-016-2820-1
Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation
2022 · Science Translational Medicine · 45 citations
https://doi.org/10.1126/scitranslmed.aax8933
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat